Home » Topics » Regulatory

Regulatory
RSS

Janssen completes phase III trials of sustained-release formulation of Risperdal

Feb. 26, 2001

Vita-Invest's combination therapy for hypertension completes phase III

Feb. 23, 2001

Therapeutic agents for drug addiction, withdrawal, etc., claimed by Knoll

Feb. 22, 2001

Protopic for severe atopic dermatitis launched in U.S.

Feb. 20, 2001

Altace approved in Canada for expanded indication

Feb. 20, 2001

Novartis receives FDA approval for Foradil Aerolizer for asthma maintenance therapy

Feb. 20, 2001

FDA advisory committee recommends approval of injectable ziprasidone

Feb. 16, 2001

New oral formulation of Zomig approved by FDA

Feb. 15, 2001

Intramuscular formulation of Zyprexa clears hurdle on the way to FDA approval

Feb. 15, 2001

First oral chemotherapy for treatment of metastatic colorectal cancer approved in Europe

Feb. 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...